400 related articles for article (PubMed ID: 31652273)
1. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
Tomlinson J; Millward A; Stenhouse E; Pinkney J
Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose metabolism in women with polycystic ovary syndrome.
Vrbikova J; Fanta M; Cibula D; Vondra K; Bendlova B
Gynecol Obstet Invest; 2009; 68(3):186-90. PubMed ID: 19672087
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA; Chung H; Cho WY
Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613
[TBL] [Abstract][Full Text] [Related]
9. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.
Glueck CJ; Papanna R; Wang P; Goldenberg N; Sieve-Smith L
Metabolism; 2003 Jul; 52(7):908-15. PubMed ID: 12870169
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.
Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.
Vrbíková J; Cífková R; Jirkovská A; Lánská V; Platilová H; Zamrazil V; Stárka L
Hum Reprod; 2003 May; 18(5):980-4. PubMed ID: 12721172
[TBL] [Abstract][Full Text] [Related]
14. Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity.
Hudnut-Beumler J; Kaar JL; Taylor A; Kelsey MM; Nadeau KJ; Zeitler P; Snell-Bergeon J; Pyle L; Cree-Green M
Pediatr Diabetes; 2021 Aug; 22(5):699-706. PubMed ID: 33870630
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome.
Weerakiet S; Srisombut C; Bunnag P; Sangtong S; Chuangsoongnoen N; Rojanasakul A
Int J Gynaecol Obstet; 2001 Nov; 75(2):177-84. PubMed ID: 11684113
[TBL] [Abstract][Full Text] [Related]
16. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.
Legro RS; Gnatuk CL; Kunselman AR; Dunaif A
J Clin Endocrinol Metab; 2005 Jun; 90(6):3236-42. PubMed ID: 15797965
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
[TBL] [Abstract][Full Text] [Related]
18. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.
Norman RJ; Masters L; Milner CR; Wang JX; Davies MJ
Hum Reprod; 2001 Sep; 16(9):1995-8. PubMed ID: 11527911
[TBL] [Abstract][Full Text] [Related]
19. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
Wild S; Pierpoint T; McKeigue P; Jacobs H
Clin Endocrinol (Oxf); 2000 May; 52(5):595-600. PubMed ID: 10792339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
